Apoptosis

Apoptosis(凋亡)

As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.

Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.

Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.

Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.

Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.

Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.

One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.

p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.

Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9). 

Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.

References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.

研究方向

Apoptosis 相关产品(2721)

  • GC35913 structure
    GC35913Durvalumab
    CAS: 1428935-60-7
    纯度: >99.50%

    Durvalumab (anti-PD-L1) is a selective, high affinity human IgG1 mAb that blocks programmed cell death ligand-1 (PD-L1) binding to PD-1 (IC50=0.1 nM) and CD80 (IC50=0.04 nM). MW=146.3 kDa.

  • GC35980 structure
    GC35980Emricasan
    CAS: 254750-02-2
    纯度: >99.50% / >98.00% / >98.50%

    Emricasan是一种口服有效、不可逆的广谱胱天蛋白酶抑制剂,具有良好的药代动力学特征。

  • GC35997 structure
    GC35997Epirubicin
    CAS: 56420-45-2

    Epirubicin是一种具有口服活性的DNA topoisomerase II特异性抑制剂,IC 50 为12μM。

  • GC36046 structure
    GC36046Fimasartan
    CAS: 247257-48-3
    纯度: >98.00%

    Fimasartan (Kanarb) is a non-peptide angiotensin II receptor antagonist (ARB) with noncompetitive, insurmountable binding with the AT1 receptor. It is used for the treatment of hypertension and heart failure.

  • GC36050 structure
    GC36050Flavokawain C
    CAS: 37308-75-1
    纯度: >98.00%

    Flavokawain C 是存在卡瓦胡椒根中的天然查尔酮。Flavokawain C 对多种人类癌症细胞系产生细胞毒性,对 HCT 116 细胞作用的 IC50 值为 12.75 μM。

  • GC36065 structure
    GC36065Formosanin C
    CAS: 50773-42-7
    纯度: >98.00% / >99.00%

    Polyphyllin B (Formosanin C, FC), a diosgenin saponin isolated from Paris formosana, is an immunomodulator with antitumor activity. Polyphyllin B (Formosanin C, FC) induces apoptosis.

  • GC36103 structure
    GC36103Galanthamine hydrobromide
    CAS: 1953-04-4
    纯度: >98.00%

    Galanthamine氢溴酸盐是长效的中心活性的乙酰胆碱酯酶(AChE)抑制剂,IC50为410 nM,同时是神经元烟碱乙酰胆碱受体的变构增强剂。

  • GC36106 structure
    GC36106Gamma-glutamylcysteine (TFA)
    CAS: 283159-88-6

    Gamma-glutamylcysteine (TFA) ((γ-glutamylcysteine (TFA))是谷胱甘肽 (GSH) 合成的中间体,一种作为抗氧化酶谷胱甘肽过氧化物酶 (GPx) 的必需辅助因子的二肽。 Gamma-glutamylcysteine (TFA) 上调抗炎细胞因子 IL-10 的水平,降低促炎细胞因子 (TNF-α,IL-6 和 IL-1β) 的水平,并减弱在寡聚 Aβ40 处理的星形胶质细胞中金属蛋白酶活性的变化。

  • GC36114 structure
    GC36114Ganoderenic acid D
    CAS: 100665-43-8

    Ganoderenic acid D 是一种灵芝提取物 (GLE),三萜。 Ganoderenic acid D 通过诱导细胞周期停滞和细胞凋亡 apoptosis 来抑制癌细胞的增殖。

  • GC36122 structure
    GC36122Gardenin B
    CAS: 2798-20-1

    Gardenin B 是从 Baccharis scandens 中分离出的一种黄酮类化合物。Gardenin B 能诱导人白血病细胞死亡,诱导的凋亡发生与多个 caspases 相关。

  • GC36130 structure
    GC36130Gemcitabine elaidate
    CAS: 210829-30-4
    纯度: >98.00%

    A prodrug form of gemcitabine

  • GC36132 structure
    GC36132Genistein 8-c-glucoside
    CAS: 66026-80-0
    纯度: >99.00%

    Genistein 8-c-glucoside (G8CG) 是从 Lupinus luteus L 花中分离的一种天然葡萄糖苷。Genistein 8-c-glucoside 诱导线粒体膜去极化并诱导细胞凋亡 (apoptosis)。

  • GC36137 structure
    GC36137Ginsenoside F4
    CAS: 181225-33-2

    Ginsenoside F4 (GF4),人参皂甙,从三七或红参中分离。Ginsenoside F4 (GF4) 通过诱导凋亡 (apoptosis) 对人淋巴细胞瘤 JK 细胞具有抑制作用。Ginsenoside F4 (GF4) 抑制 IL-1β 处理的软骨细胞中基质金属蛋白酶 13 (MMP 13) 的表达,阻断兔软骨组织培养中的软骨损坏,具有防止病变组织的软骨胶原基质分解的治疗潜力。

  • GC36151 structure
    GC36151Glucagon-Like Peptide (GLP) II, human
    CAS: 89750-15-2

    Glucagon-Like Peptide (GLP) II, human 是由原胰高血糖素 C 端衍生的33 氨基酸肽,主要由肠道L细胞产生。Glucagon-Like Peptide (GLP) II 可刺激肠粘膜生长,减少肠细胞的凋亡。

  • GC36167 structure
    GC36167GMB-475
    CAS: 2490599-18-1
    纯度: >99.00%

    GMB-475 is a proteolysis-targeting chimera (PROTAC) that allosterically targets BCR-ABL1 protein and recruit the E3 ligase Von Hippel-Lindau (VHL), resulting in ubiquitination and subsequent degradation of the oncogenic fusion protein.

  • GC36170 structure
    GC36170GNE684
    CAS: 2438637-64-8

    GNE684 是一种有效的受体相互作用蛋白 1 (RIP1) 抑制剂,作用于人类、小鼠与大鼠 RIP1 的 Kiapp 值分别为 21 nM、189 nM 和 691 nM。

  • GC36179 structure
    GC36179Gomisin N
    CAS: 69176-52-9
    纯度: >98.00%

    Gomisin N 是从Schisandra chinensis 中分离得到的,具有良好的镇静催眠作用。Gomisin N 有治疗过敏的潜力。Gomisin N 还是一种具有通过诱导癌细胞凋亡从而发挥抗肿瘤增值作用的候选药物。

  • GC36189 structure
    GC36189GSK2983559
    CAS: 1579965-12-0
    纯度: >98.00%

    A RIPK2 inhibitor

  • GC36229 structure
    GC36229Hirsutine
    CAS: 7729-23-9
    纯度: >99.00%

    Hirsutine,一种 Uncaria rhynchophylla 的吲哚生物碱,具有抗癌活性。Hirsutine 诱导细胞凋亡,并且是一种有效的 Dengue virus 抑制剂,具有低毒性。

  • GC36270 structure
    GC36270Hydrolyzed Fumonisin B1
    CAS: 145040-09-1

    Hydrolyzed Fumonisin B1 (Aminopentol) 是真菌毒素 fumonisin B1 (FB1) 的主要水解产物,具有较弱的抑制神经酰胺合成酶的作用。

  • GC36283 structure
    GC36283Hypocrellin B
    CAS: 123940-54-5
    纯度: >98.00%

    A fungal metabolite

  • GC36286 structure
    GC36286IACS-10759 Hydrochloride
    CAS: 1807523-99-4
    纯度: >99.50%

    IACS-10759 Hydrochloride 是一种具有口服活性的强效线粒体复合物 I 的氧化磷酸化 (OXPHOS) 抑制剂。 IACS-10759 Hydrochloride 在依赖 OXPHOS 的脑癌和急性髓性白血病 (AML) 模型中抑制增殖并诱导细胞凋亡。 IACS-10759 Hydrochloride 具有用于复发/难治性 AML 和实体瘤研究的潜力。

  • GC36308 structure
    GC36308Indibulin
    CAS: 204205-90-3
    纯度: >99.00%

    An inhibitor of microtubule assembly

  • GC36343 structure
    GC36343Isosilybin A
    CAS: 142796-21-2
    纯度: >99.00%

    Isosilybin A 是一种从 silymarin 中分离出来的黄酮木脂素,具有抗前列腺癌 (PCA) 活性。Isosilybin A 抑制癌细胞增殖并诱导 G1 期停滞和凋亡,通过靶向 Akt-NF-κB-androgen receptor (AR) 轴激活前列腺癌细胞的凋亡机制。